Lehman David Aaron sold $3K of LUNG
Lehman David Aaron (GENERAL COUNSEL) sold 2,264 shares of Pulmonx Corp (LUNG) at $1.54 on 2026-06-01.
How this was made
The 30-second read
Why it matters
The filing documents an open-market sale by the general counsel; it does not include any operational, regulatory, or financial update.
Market read
Primarily a sentiment/positioning datapoint; not a standalone catalyst for trading.
What to watch
Insider sales can be driven by taxes, diversification, or pre-existing personal liquidity needs; absence of a 10b5-1 plan does not by itself confirm negative expectations.
Background
The article is an SEC Form 4 insider transaction disclosure for Pulmonx (LUNG).
Ticker impact
Pulmonx general counsel sold 2,264 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-01.
Likely limited near-term impact; any effect would be small and sentiment-driven unless followed by additional insider activity or company news.
Form 4 insider sales are common and this specific sale is small relative to the post-transaction holdings; there is no 10b5-1 plan and no accompanying operational disclosure.
Market effects
No clear sector read-through; this is a single-company insider transaction with no stated business change.
None indicated.
None indicated.
Counterpoint
Without a 10b5-1 plan, the sale could be discretionary, but the disclosed size and lack of accompanying news make it unlikely to signal a material fundamental shift.
Key entities
- issuerPulmonx Corp
Company whose insider transaction was disclosed on SEC Form 4.
- insiderLehman David Aaron
General counsel who sold 2,264 shares at $1.54/share.
